Big pharma clients might have the most arduous content review process of any vertical, with tight deadlines, deep research, and difficult regulatory restrictions to navigate. Campaigns range from traditional advertising to sales collateral and symposia content.


Wilson's Disease is a genetic disorder in which copper accumulates in the the body's tissue, resulting in neurologic and psychiatric symptoms, as well as liver disease. It is most easily treated with a zinc acetate medication to reduce copper absorption. Galzin is the drug most commonly prescribed for Wilson's Disease.


Ultracet is a synthetic analgesic used to treat moderately-severe pain for a wide range of applications. The user guide is a tool for pharmaceutical sales representatives to aid them on physician calls. These campaigns ran on a quarterly cycle, with a new batch of materials being created every three months.


Levaquin is an antibiotic used to treat pneumonia, chronic bronchitis, and a multitude of various infections. Collateral and leave-behinds were rolled out to pharmaceutical reps each quarter to aid them in their  in-person physicians sales calls.


MegaceES is used for the treatment of cachexia (wasting syndrome) appetite loss, severe malnutrition and significant weight loss in AIDS patients. It is a reformulated, improved formula from the original Megace, and offers improved bioavailability and better absorption on an empty stomach. A smaller dosage is much easier for patients to endure.


Purinethol is an immunosuppressive drug used to treat leukemia. Known for its safety and minimal side effects (compared to other cancer treatments) the campaign focused on its  longevity in putting patients in remission. 

In recent years, it has been increasingly used off-label to treat Crohn's Disease, often diagnosed during teenaged years. Drugs used to treat Crohn's often have embarrassing physical side effects like acne and weight gain. Concepts ranged from highlighting the drug's 50-year history to the benefits of few side effects.